BEAM Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 jun 2024 @ 21:52):
Our systems believe the stock currently is overvalued by -0.02% compare to its pairs and should correct downwards.

Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States...

Stats
Dagens volum	1.00M
Gjennomsnittsvolum	1.38M
Markedsverdi	2.05B
EPS	$-1.210 ( Q1 \| 2024-03-31 )
Neste inntjeningsdato	( $-1.130 ) 2024-08-13
Last Dividend	$0.225 ( 2014-02-04 )
Next Dividend	$0 ( N/A )
P/E	-15.56 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0260 (0.10%)

AADI -5.88%

ABCL 0.92%

ABCM 0.04%

ABEO -3.08%

ABIO -0.30%

ABOS 1.40%

ABSI 3.40%

ABUS -1.15%

ABVX -3.00%

ACAD -0.35%

ACER -17.95%

ACET -9.18%

ACGN 1.29%

ACHL -1.70%

ACHV 2.16%

ACIU -0.50%

ACLX -0.37%

ACRV -4.29%

ACST -3.58%

ACXP 3.69%

ADAG 7.14%

ADAP -3.72%

ADGI 0.87%

ADIL -2.66%

ADMA -1.13%

ADPT 0.44%

ADTX -3.47%

ADVM 1.30%

ADXN -1.60%

AEON -4.67%

AEZS -2.49%

AFMD -3.15%

AGEN -4.00%

AGIO -2.57%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 8.21%

AKRO -2.26%

AKTX -5.23%

AKUS 0.00%

ALBO 0.00%

ALDX -2.10%

ALEC -0.80%

ALGS -0.37%

ALKS 1.96%

ALLK -11.39%

ALLO -2.50%

ALLR -1.63%

ALNA 3.16%

ALNY 2.24%

ALPN 0.02%

ALPX 0.00%

ALRN -2.63%

ALT -15.32%

ALVR -0.79%

ALXN 0.00%

ALXO -10.57%

ALZN 5.10%

AMRN -4.30%

AMTI -3.13%

ANAB 1.55%

ANEB 7.95%

ANGN 0.00%

ANIX -3.64%

ANL -0.14%

ANNX 3.71%

ANPC -3.15%

APGE 2.11%

APGN 8.48%

APGNW 30.65%

APLM -3.25%

APLS 0.35%

APLT 1.13%

APM 1.47%

APOP 0.38%

APRE -3.13%

APTO 0.62%

APTX 3.17%

APVO 3.21%

ARAV -13.39%

ARCT -6.62%

ARDS -12.13%

ARDX 2.24%

ARGX -0.79%

ARNA 0.00%

ARPO -0.90%

ARQT -3.33%

ARTL -2.50%

ARTLW 0.00%

ARVN 7.03%

ARWR -2.38%

ASLN -2.45%

ASMB -5.55%

ASND -2.25%

ATAI -3.33%

ATHA 7.76%

ATHE 0.08%

ATHX -33.50%

ATNF 2.18%

ATOS 4.83%

ATRA -6.27%

ATXI 1.09%

ATXS -0.33%

AUPH -0.81%

AURA 4.71%

AUTL -3.16%

AVBP -3.69%

AVEO 0.00%

AVIR -1.75%

AVRO -1.41%

AVTE -0.68%

AVTX -4.26%

AVXL -5.68%

AXLA 0.00%

AXSM -1.32%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 1.28%

BCAB -7.17%

BCDA -0.85%

BCDAW -46.41%

BCEL 0.00%

BCLI 3.09%

BCRX 1.73%

BCTX 13.26%

BCTXW 1.97%

BCYC 1.15%

BDRX -5.56%

BDTX 0.21%

BEAM 2.68%

BFRA -2.91%

BGNE -2.91%

BIOR -3.83%

BIVI 2.38%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.89%

BLTE -1.25%

BLU 0.03%

BLUE -4.84%

BMEA -15.26%

BMRN 0.16%

BNOX 4.46%

BNTC -2.39%

BNTX -2.10%

BOLD -11.17%

BOLT 0.33%

BPMC -2.33%

BPTH -4.05%

BPTS -13.47%

BRNS -0.37%

BRTX -5.90%

BTAI 13.08%

BTTX 20.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 2.78%

CABA 1.31%

CADL 1.42%

CALA 0.00%

CALC -3.82%

CALT -1.59%

CAPR -0.43%

CARA -12.08%

CARM 6.35%

CASI -1.18%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 1.22%

CCCC -1.59%

CCXI 0.00%

CDAK 0.00%

CDIO -4.66%

CDIOW 24.00%

CDMO -1.55%

CDMOP 0.04%

CDT -5.71%

CDTTW -39.60%

CDTX -6.36%

CDXC 9.61%

CDXS 9.66%

CELC -3.43%

CELU 0.74%

CELUW 11.80%

CERC -1.68%

CERE -1.42%

CERO -5.02%

CEROW -10.18%

CFRX -27.95%

CGEM 0.07%

CGEN -3.59%

CGON -2.64%

CGTX -3.43%

CHMA -6.00%

CHRS 4.75%

CINC 0.00%

CING -3.90%

CINGW 34.95%

CKPT -0.96%

CLBS -16.75%

CLDX -0.41%

CLGN -0.50%

CLLS -3.11%

CLNN -2.50%

CLNNW 0.00%

CLRB 6.47%

CLSD -2.40%

CLSN -0.68%

CLVS 0.00%

CMMB -2.94%

CMND 3.23%

CMPI 0.00%

CMPX 0.93%

CMRA 0.00%

CMRAW 33.33%

CMRX -4.43%

CNCE 0.00%

CNSP -34.50%

CNST 0.00%

CNTA 0.79%

CNTB -1.50%

CNTX -7.76%

COCP -1.83%

COEPW 32.45%

COGT -2.52%

CORT 3.32%

COYA -2.42%

CPRX -1.25%

CRBP -1.40%

CRBU -7.95%

CRDF 2.65%

CRGX -1.95%

CRIS -2.64%

CRNX -5.86%

CRSP 0.95%

CRTX 2.63%

CRVO -6.25%

CRVS 0.00%

CSBR -0.19%

CTCX 1.20%

CTIC 0.06%

CTMX -3.31%

CTNM 5.57%

CTXR -4.57%

CUE -2.42%

CVAC -4.95%

CVKD -2.34%

CWBR 2.80%

CYAD -12.96%

CYCC 19.50%

CYCCP 5.28%

CYCN 7.81%

CYT -2.27%

CYTK -2.80%

CYTO 0.00%

DARE 0.86%

DAWN -0.15%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 31.86%

DNLI -1.79%

DNTH -2.31%

DOMH 1.06%

DRMA -2.57%

DRMAW -1.25%

DRNA 0.00%

DRTS 0.46%

DRTSW 0.00%

DRUG -0.10%

DSGN -2.42%

DTIL -0.21%

DYAI 9.68%

EARS -1.77%

EDIT -2.92%

EDSA 4.14%

EFTR 1.50%

EFTRW -51.85%

EIGR -9.21%

ELAB -3.01%

ELDN 7.17%

ELEV -1.45%

ELOX 10.77%

ELTX -3.38%

ELVN -1.49%

ELYM 5.44%

ENGN 0.49%

ENGNW -21.67%

ENLV -1.45%

ENOB 1.79%

ENSC 6.55%

ENTA -0.90%

ENTO -4.97%

ENTX 0.53%

ENVB -0.02%

EPIX -2.68%

EPRX -2.87%

EPZM 0.00%

EQ -1.24%

EQRX -2.09%

EQRXW 0.00%

ERAS 6.27%

ERNA -2.78%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -5.98%

ETON 2.44%

ETTX 0.00%

EVAX 0.00%

EVGN 3.46%

EVLO 0.00%

EWTX 0.29%

EXAI -0.47%

EXEL 0.94%

EYEG -0.69%

EYEN 0.00%

EYPT -0.12%

FATE -12.25%

FBIO 0.90%

FBIOP 0.87%

FBLG -10.30%

FBRX -0.04%

FDMT -4.73%

FENC -2.74%

FGEN -9.87%

FHTX 8.59%

FIXX 0.77%

FMTX 0.00%

FNCH 0.00%

FOLD -1.65%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 0.71%

FULC 2.26%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT 0.00%

GANX -1.54%

GBIO -1.06%

GBT 0.01%

GDTC 2.05%

GERN -1.44%

GHRS -4.27%

GLMD -2.48%

GLPG -1.79%

GLSI 9.27%

GLTO -3.90%

GLUE -2.37%

GLYC -15.08%

GMAB -0.37%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.34%

GNLX -3.98%

GNPX -4.41%

GNTA 3.94%

GOSS -7.72%

GOVX -6.36%

GOVXW 10.89%

GPCR -5.83%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -2.17%

GRTX -1.66%

GTHX 2.27%

GUTS 0.12%

GXGXW 41.67%

GYRE -5.95%

HALO -0.92%

HARP 0.09%

HCWB -3.76%

HEPA -3.50%

HGEN -84.62%

HILS 5.66%

HLVX 0.38%

HOOK 1.19%

HOTH -3.67%

HOWL 0.43%

HRMY 3.16%

HRTX 8.36%

HSTO 0.00%

HUMA 2.03%

HUMAW -6.25%

IBRX -5.78%

ICCC -2.10%

ICPT 0.21%

ICU 19.03%

ICUCW 4.86%

ICVX -0.91%

IDRA -23.04%

IDYA -3.05%

IFRX -3.52%

IGMS -2.12%

IKNA -1.79%

IKT -2.08%

IMAB -0.58%

IMCR -3.27%

IMGN 0.02%

IMGO 0.00%

IMMP 5.51%

IMMX -3.88%

IMNM 3.72%

IMNN 1.77%

IMPL -27.27%

IMRA 15.96%

IMRN -0.40%

IMRX -3.50%

IMTX -1.25%

IMTXW 6.00%

IMUX -5.56%

IMV 0.00%

IMVT -3.81%

INAB -1.12%

INBX -3.11%

INCY -2.10%

INDP 6.88%

INFI -52.38%

INKT 0.00%

INM 3.06%

INMB 2.66%

INO 2.02%

INSM -0.89%

INTS -3.73%

INVA 0.81%

INZY 1.14%

IOBT -7.48%

IONS 1.68%

IOVA -3.96%

IPA 1.08%

IPHA 2.54%

IPSC -2.34%

IRON -1.88%

ISEE 0.38%

ITOS 3.01%

ITRM 1.36%

IVA 6.96%

IVVD 0.41%

JAGX 0.52%

JANX -4.94%

JAZZ -0.75%

JNCE 0.00%

JSPR -1.51%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.49%

KALV -2.42%

KDNY 0.22%

KMPH -0.34%

KNSA -2.48%

KNTE -0.38%

KOD -8.70%

KPRX -5.76%

KPTI -8.85%

KRBP -10.00%

KRON 1.61%

KROS -0.33%

KRRO -1.59%

KRTX 0.03%

KRYS 0.96%

KTRA 9.85%

KTTA -0.65%

KTTAW 0.92%

KURA 0.98%

KYMR -3.50%

KYTX -5.43%

KZIA 6.13%

KZR -1.77%

LABP 0.57%

LBPH 0.63%

LBPS 0.00%

LBPSW 14.81%

LEGN 3.22%

LENZ -3.21%

LEXX 0.58%

LEXXW -14.63%

LGND -0.82%

LGNDV 0.00%

LGVN -9.04%

LIAN -8.28%

LIFE 2.70%

LIPO -5.29%

LIXT -9.76%

LIXTW 46.21%

LJPC -0.32%

LMNL 0.12%

LOGC 0.43%

LPCN -4.36%

LPTX -1.10%

LQDA 0.37%

LRMR -0.50%

LSTA -1.68%

LTRN 5.49%

LUMO 0.67%

LVTX -4.12%

LXEO -13.57%

LXRX -1.18%

LYEL -36.03%

LYRA 4.22%

MACK 0.10%

MBIO -11.90%

MBRX -1.43%

MCRB 0.95%

MDGL -1.79%

MDNA -13.16%

MDWD 3.36%

MDXG -1.62%

MEIP 0.70%

MESO -1.48%

MGNX -5.24%

MGTA -7.74%

MGTX -0.83%

MGX -0.54%

MIRM -0.57%

MIRO 0.59%

MIST 1.92%

MITO 0.00%

MLEC -6.54%

MLECW 2.31%

MLND -5.36%

MLTX 0.86%

MLYS -8.42%

MNKD -0.67%

MNMD 2.76%

MNOV 1.41%

MNPR -9.34%

MOLN 0.76%

MOR 0.62%

MORF -2.89%

MREO 0.14%

MRKR -0.43%

MRNA -10.79%

MRNS -5.99%

MRSN -3.57%

MRTX -0.17%

MRUS 0.69%

MRVI 1.46%

MTCR -1.29%

MTEM 7.43%

MTP -18.50%

MURA -4.32%

MYMD 2.17%

NAMS -0.15%

NAMSW 0.64%

NAUT 1.11%

NBRV 0.71%

NBSE -1.56%

NBTX 8.91%

NCNA -0.18%

NERV -0.32%

NEXI 1.50%

NGM -1.28%

NGNE 3.57%

NKGN 10.92%

NKGNW -20.00%

NKTR 1.87%

NKTX -2.86%

NLSP 5.63%

NLSPW 26.67%

NMRA -1.26%

NMTR -42.97%

NOVN -24.84%

NRBO 14.85%

NRIX -1.49%

NRSN 0.78%

NRSNW 0.00%

NRXP -8.92%

NRXPW 18.33%

NRXS -1.20%

NTBL 2.63%

NTEC -12.45%

NTHI 0.00%

NTLA -4.71%

NTRBW -31.07%

NUVL -1.83%

NVAX -5.75%

NVCT -7.81%

NVIV -34.28%

NXTC -5.88%

NYMX -0.05%

OABI 3.04%

OABIW -10.06%

OBIO 0.00%

OBSV 0.00%

OCEA -4.23%

OCGN 7.63%

OCS -1.00%

OCUL 0.38%

OCUP 0.00%

ODT -4.27%

OKYO 1.72%

OLMA -4.60%

OMER -2.57%

OMGA -2.08%

ONCO 6.16%

ONCR -3.08%

ONCS 31.87%

ONCT -2.04%

ONCY 2.90%

ONTX -0.47%

ONVO 2.00%

OPNT 0.00%

OPT -5.15%

ORGS -0.69%

ORIC -3.56%

ORMP 16.29%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -0.28%

OVID 0.40%

OYST 0.00%

PALI -0.48%

PASG 0.00%

PBLA -7.50%

PBM -4.75%

PBYI 4.57%

PCSA 0.95%

PCVX 0.67%

PDSB -4.75%

PEPG 1.31%

PGEN -6.39%

PHAR 1.99%

PHAS 0.00%

PHAT 0.39%

PHIO -3.55%

PHIOW 36.47%

PHVS -6.50%

PHXM -5.20%

PIRS 0.11%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -2.56%

PLUR 10.34%

PMN -5.55%

PMVP -1.49%

PNT 0.16%

PPBT 1.64%

PRAX 4.77%

PRDS 0.93%

PRLD -3.43%

PROG -3.47%

PROK 2.24%

PRQR 1.20%

PRTA -3.37%

PRTC 0.49%

PRTG 1.40%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -12.20%

PSTX -4.26%

PTCT 0.09%

PTE -0.82%

PTGX 0.91%

PTIXW -48.41%

PULM 1.56%

PXMD 4.76%

PYPD 1.71%

PYXS 4.58%

QLGN -5.84%

QNCX 2.23%

QNRX 0.84%

QSI -28.89%

QSIAW -9.44%

QTTB 3.65%

QURE -1.46%

RAIN -1.63%

RANI 4.28%

RAPT -1.78%

RARE 1.95%

RCKT -10.27%

REGN -0.16%

RENB -3.42%

REPL -2.49%

RETA 0.02%

REUN -0.89%

REVB -1.86%

REVBU 3.46%

REVBW 5.00%

RGLS -5.61%

RGNX -6.25%

RIGL -6.24%

RLAY -5.71%

RLMD -0.33%

RLYB -5.37%

RNA 2.44%

RNAC 0.58%

RNAZ -1.92%

RNXT 2.23%

ROIV -2.17%

ROIVW 4.56%

RPHM -1.86%

RPRX -0.74%

RPTX -1.17%

RUBY 2.70%

RVLP -32.05%

RVMD -0.37%

RVMDW -29.90%

RVNC -0.43%

RVPH -0.40%

RVPHW -5.28%

RXDX 0.09%

RXRX -6.08%

RYTM -5.71%

RYZB 0.02%

RZLT 3.10%

SABS -1.37%

SABSW -5.53%

SAGE -0.28%

SANA -2.21%

SAVA -4.35%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 1.29%

SCPH 11.62%

SCPS 0.00%

SEEL -3.54%

SEER 0.29%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -5.08%

SGMT -4.84%

SGTX -2.56%

SIOX 22.63%

SLDB -2.33%

SLGL 5.23%

SLN -8.77%

SLNO 0.58%

SLRX 0.40%

SLS -3.85%

SMMT -3.37%

SNDX 2.41%

SNGX 3.40%

SNPX -2.77%

SONN -1.59%

SPPI -0.49%

SPRB -1.63%

SPRC -3.29%

SPRO 0.38%

SRNE 0.00%

SRPT -0.70%

SRRA 0.00%

SRRK -1.61%

SRZN -2.45%

STAB 0.00%

STOK -6.88%

STRO -1.34%

STSA 0.00%

STTK 7.03%

SURF -0.93%

SVRA -4.34%

SWTX 0.58%

SYBX 0.00%

SYRS -2.07%

TALS -0.73%

TARA -7.62%

TARS -2.13%

TBPH 0.18%

TCBP 5.49%

TCDA 0.00%

TCON -0.70%

TCRR 0.00%

TCRT 4.48%

TCRX -2.58%

TECH -1.14%

TENX -0.32%

TERN -6.62%

TFFP -11.17%

TGTX -7.92%

THRX 0.12%

TIL -1.22%

TLC 0.00%

TLSA -4.65%

TNGX -3.67%

TNXP -9.65%

TNYA -6.83%

TPST 5.34%

TRDA -4.81%

TRVI 1.92%

TRVN 3.15%

TSHA -17.04%

TSVT -4.20%

TTNP -6.05%

TVTX 3.83%

TYRA -7.50%

UBX -2.73%

UNCY -4.00%

URGN 3.85%

UTHR -0.42%

VACC 11.36%

VALN -3.15%

VAXX 118.75%

VBIV -0.79%

VBLT -8.77%

VCEL 1.65%

VCNX 9.30%

VCYT -0.95%

VERA -4.40%

VERU 1.51%

VERV -3.54%

VIGL 1.07%

VINC 2.81%

VIR -1.14%

VIRI -5.66%

VIRX 3.47%

VKTX -1.11%

VLON -13.04%

VNDA -3.01%

VOR -6.45%

VRCA 0.57%

VRDN -3.21%

VRNA -1.73%

VRPX 3.58%

VRTX -0.11%

VSTM 4.93%

VTGN -2.26%

VTVT 1.28%

VTYX -1.88%

VXRT -0.54%

VYGR -0.64%

VYNE -5.80%

VYNT 7.78%

WINT -2.72%

WVE -8.07%

XBIO 1.03%

XBIT 4.17%

XCUR 0.23%

XENE -0.87%

XERS 4.76%

XFOR 5.76%

XLO 3.06%

XLRN 0.00%

XNCR 0.26%

XOMA -8.25%

XOMAO -0.45%

XOMAP -0.82%

XRTX -7.96%

YMAB -1.72%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.70%

ZNTL -1.07%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-06-05	Shaw Christi	Buy	23 114	Stock Option (Right to Buy)
2024-06-05	Maraganore John	Buy	23 114	Stock Option (Right to Buy)
2024-06-05	Ho Carole	Buy	23 114	Stock Option (Right to Buy)
2024-06-05	Cooper Graham K	Buy	23 114	Stock Option (Right to Buy)
2024-06-05	Walsh Kathleen E	Buy	23 114	Stock Option (Right to Buy)

INSIDER POWER
-4.59
Last 98 transactions
Buy: 1 639 144 \| Sell: 1 801 150

Korrelasjon (AI algo v.1.1b): Overvalued: -0.02% $24.91 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Volum Korrelasjon

Lang: 0.44 (neutral)

Kort: 0.69 (moderate)

Signal:(59.074) Neutral

Beam Therapeutics Inc Korrelasjon

10 Mest positive korrelasjoner
OZEM	1
DFLI	0.939
CRSP	0.923
ORGN	0.906
HLP	0.902
NBBK	0.894
MAMA	0.893
FONR	0.893
BUJA	0.892
AAIDX	0.884

10 Mest negative korrelasjoner
RDZN	-0.894
PTLO	-0.89
BRLSW	-0.881
CLMB	-0.88
RENB	-0.878
FUFUW	-0.871
NWGL	-0.869
GBLMX	-0.867
KITT	-0.867
KYTX	-0.86

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Beam Therapeutics Inc Korrelasjon - Valuta/Råvare

-0.09
( neutral )

0.69
( moderate )

0.00
( neutral )

0.65
( moderate )

0.37
( neutral )

0.62
( weak )

Beam Therapeutics Inc Økonomi

Annual	2023
Omsetning:	$377.71M
Bruttogevinst:	$357.70M (94.70 %)
EPS:	$-1.720

FY	2023
Omsetning:	$377.71M
Bruttogevinst:	$357.70M (94.70 %)
EPS:	$-1.720

FY	2022
Omsetning:	$60.92M
Bruttogevinst:	$38.34M (62.94 %)
EPS:	$-3.76

FY	2021
Omsetning:	$51.84M
Bruttogevinst:	$51.84M (100.00 %)
EPS:	$-5.77

Financial Reports:

No articles found.

Beam Therapeutics Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Beam Therapeutics Inc Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0.664 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	$0.190	2011-11-07
Last Dividend	$0.225	2014-02-04
Next Dividend	$0	N/A
Payout Date	2014-03-03
Next Payout Date	N/A
# dividends	10	--
Total Paid Out	$2.16	--
Avg. Dividend % Per Year	0.00%	--
Score	1.6	--
Div. Sustainability Score	0.664
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-09-18)

$0 Estimate 0.00 %

Dividend Stability

0.04 Very Bad

Dividend Score

1.60

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
04 Feb 2014	$0.225	23 Jan 2014	06 Feb 2014	03 Mar 2014
04 Nov 2013	$0.225	20 Sep 2013	06 Nov 2013	02 Dec 2013
12 Aug 2013	$0.225	31 Jul 2013	14 Aug 2013	03 Sep 2013
06 May 2013	$0.225	24 Apr 2013	08 May 2013	03 Jun 2013
04 Feb 2013	$0.225	25 Jan 2013	06 Feb 2013	01 Mar 2013
05 Nov 2012	$0.210	04 Oct 2012	30 Nov -0001	03 Dec 2012
06 Aug 2012	$0.210	24 Jul 2012	30 Nov -0001	04 Sep 2012
07 May 2012	$0.210	26 Apr 2012	30 Nov -0001	01 Jun 2012
06 Feb 2012	$0.210	30 Jan 2012	30 Nov -0001	01 Mar 2012
07 Nov 2011	$0.190	30 Nov -0001	30 Nov -0001	01 Dec 2011

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
OXLC	Dividend Diamond	2024-09-16	Monthly	14	15.03%	9.60
DMLP	Dividend Diamond	2024-04-26	Quarterly	22	10.71%	9.35
OXSQ	Dividend Diamond	2024-09-16	Monthly	21	12.73%	9.02
ARLP	Dividend Royal	2024-05-07	Quarterly	26	9.67%	8.87
PNNT	Dividend Royal	2024-06-14	Monthly	18	9.49%	8.82
MFIC	Dividend Royal	2024-06-11	Quarterly	21	10.89%	8.79
SPOK	Dividend Royal	2024-05-23	Quarterly	20	8.73%	8.72
PSEC	Dividend Royal	2024-06-25	Monthly	21	9.03%	8.65
SBLK	Dividend Royal	2024-06-06	Quarterly	17	13.10%	8.63
GBDC	Dividend Royal	2024-11-29	Bi-Monthly	15	8.53%	8.62

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.373	1.500	-7.47	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.0991	1.200	-3.30	-3.96	[0 - 0.3]
returnOnEquityTTM	-0.155	1.500	-2.83	-4.24	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	5.99	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	5.85	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	1.537	1.500	2.57	3.85	[0.2 - 2]
debtRatioTTM	0.124	-1.500	7.94	-10.00	[0 - 0.6]
interestCoverageTTM	-7.37	1.000	-3.84	-3.84	[3 - 30]
operatingCashFlowPerShareTTM	-1.703	2.00	-0.568	-1.135	[0 - 30]
freeCashFlowPerShareTTM	-2.07	2.00	-1.036	-2.07	[0 - 20]
debtEquityRatioTTM	0.184	-1.500	9.26	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.929	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	-0.503	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.828	1.000	-5.71	-5.71	[0.2 - 2]
assetTurnoverTTM	0.265	0.800	-1.564	-1.251	[0.5 - 2]
Total Score				0.664

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-14.70	1.000	-1.586	0	[1 - 100]
returnOnEquityTTM	-0.155	2.50	-1.819	-4.24	[0.1 - 1.5]
freeCashFlowPerShareTTM	-2.07	2.00	-0.691	-2.07	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-1.703	2.00	-0.568	-1.135	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.147	1.500	-4.31	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.385	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-2.51

Beam Therapeutics Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Beam Therapeutics Inc

Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia; and BEAM-301, a liver-targeted development candidate for the treatment of patients with Glycogen Storage Disease Type Ia. It also develops therapies for alpha-1 antitrypsin deficiency; ocular diseases; and other liver, muscle, and central nervous system disorders. The company has an alliance with Boston Children's Hospital; a research and clinical trial collaboration agreement with Magenta Therapeutics, Inc.; license agreement with Sana Biotechnology, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. It also has a research collaboration agreement with Pfizer Inc. and Apellis Pharmaceuticals, Inc.; and collaboration and license agreement with Verve Therapeutics, Inc. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.